Excellence in stroke prevention

Marie-Catherine Mousseau reports on the efficacy and safety of the new anticoagulants as presented at the Boehringer Ingelheim 'Excellence in stroke prevention and treatment' meeting. Is stroke genetic?”, “What is the true prevalence of atrial fibrillation (AF) and when does it become a risk factor for stroke?”, “How important is it to follow salt and blood pressure (BP) recommendations when it comes to stroke prevention and how low should we go?”, “Have we definitely moved away from aspirin?” Controversies These are some of the controversies addressed by Prof Martin O’Donnell, Consultant in Geriatric Medicine, Galway University Hospital, speaking at Boehringer…